Edgewise Therapeutics Inc
NASDAQ:EWTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Edgewise Therapeutics Inc
NASDAQ:EWTX
|
US |
|
Cogeco Inc
TSX:CGO
|
CA |
|
S
|
Singapore Airlines Ltd
SWB:SIA1
|
SG |
|
Tabcorp Holdings Ltd
ASX:TAH
|
AU |
|
Fasadgruppen Group AB (publ)
STO:FG
|
SE |
|
Nomad Foods Ltd
NYSE:NOMD
|
UK |
|
B
|
Bank Millennium SA
F:1HN
|
PL |
|
V
|
Vectus Biosystems Ltd
ASX:VBS
|
AU |
|
R
|
Rock Ridge Resources Inc
OTC:RRRI
|
US |
|
J
|
Journey Energy Inc
TSX:JOY
|
CA |
|
Collector Bank AB
STO:COLL
|
SE |
|
Amgen Inc
NASDAQ:AMGN
|
US |
|
OneSoft Solutions Inc
XTSX:OSS
|
CA |
|
Salora International Ltd
BSE:500370
|
IN |
|
Maha Properti Indonesia Tbk PT
IDX:MPRO
|
ID |
Bankruptcy Probability
Edgewise Therapeutics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Edgewise Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Edgewise Therapeutics Inc
NASDAQ:EWTX
|
3.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Edgewise Therapeutics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Edgewise Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
